NEUPROGRAMMIERUNG VON KREBSZELLEN

Patent europeic · EP3524672 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3524672
Numer da la dumonda
EP19165472
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
16-06-2011
Publitgà
14-08-2019
Concedì
28-05-2025
Stritgà
27-01-2026
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 5/0735 (2010.01)
C12N 5/074 (2010.01)
C12N 5/095 (2010.01)
G01N 33/569 (2006.01)
Prioritad
US 35548310 P 16.06.2010
US 38565310 P 23.09.2010
US 201061428360 P 30.12.2010
US 201161453917 P 17.03.2011
US 201161472516 P 06.04.2011
US 201161474236 P 11.04.2011
US 201161484052 P 09.05.2011
Derivà da
EP11796473
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-04-2026

    Midada

    Published in Swissreg on 09.04.2026

  2. 27-01-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    27.01.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 27.01.2026

  3. 28-05-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 28.05.2025

Partidas

Possessur

Minerva Biotechnologies Corporation

40 Bear Hill Rd., Waltham, MA 02451, US

Inventur

BAMDAD, Cynthia

Boston, MA 02115, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.